| EURO-BOSS: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma |
13 |
| Clinical factors stratifying the risk of tumor upgrading to high-grade disease in low-risk prostate cancer |
9 |
| The inducers of immunogenic cell death for tumor immunotherapy |
9 |
| Significance of stroma in biology of oral squamous cell carcinoma |
8 |
| IL-6/IL-6R pathway is a therapeutic target in chemoresistant ovarian cancer |
7 |
| Denosumab in patients with aneurysmal bone cysts: A case series with preliminary results |
6 |
| Prognostic significance of infiltrating immune cell subtypes in invasive ductal carcinoma of the breast |
6 |
| TARIBO trial: targeted therapy with or without nephrectomy in metastatic renal cell carcinoma: liquid biopsy for biomarkers discovery |
6 |
| A new prognostic model using the NCCN-IPI and neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma |
5 |
| Long noncoding RNA CCAT1 promotes cell proliferation and metastasis in human medulloblastoma via MAPK pathway |
5 |
| Chemoradiation in female patients with anal cancer: Patient-reported outcome of acute and chronic side effects |
5 |
| Management of kidney cancer patients: 2018 guidelines of the Italian Medical Oncology Association (AIOM) |
5 |
| Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol |
5 |
| Relationships among unmet needs, depression, and anxiety in non-advanced cancer patients |
4 |
| Survival after second and subsequent recurrences in osteosarcoma: a retrospective multicenter analysis |
4 |
| Impact of coexistent adenomyosis on outcomes of patients with endometrioid endometrial cancer: a propensity score-matched analysis |
4 |
| Semaphorin 4D promotes the proliferation and metastasis of bladder cancer by activating the PI3K/AKT pathway |
4 |
| Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in rectal cancer patients following neoadjuvant chemoradiotherapy |
4 |
| The evolving landscape of criteria for evaluating tumor response in the era of cancer immunotherapy: From Karnofsky to iRECIST |
4 |
| Ra-223-chloride therapy in men with hormone-refractory prostate cancer and skeletal metastases: Real-world experience |
4 |
| What shall I do when I grow up? Adolescents with cancer on the Youth Project in Milan play with their imagination and photography |
3 |
| Radium-223 for the treatment of bone metastases in castration-resistant prostate cancer: when and why |
3 |
| Trends of colorectal cancer incidence and mortality rates from 2003 to 2014 in Italy |
3 |
| Real-world evidence in metastatic renal cell carcinoma |
3 |
| Moderate hypofractionated helical tomotherapy for localized prostate cancer: preliminary report of an observational prospective study |
3 |
| Insights into inflammasome and its research advances in cancer |
3 |
| Reliability and validity assessment of administrative databases in measuring the quality of rectal cancer management |
3 |
| MEF2C promotes gefitinib resistance in hepatic cancer cells through regulating MIG6 transcription |
3 |
| Entering the third decade of experience with octreotide LAR in neuroendocrine tumors: A review of current knowledge |
3 |
| Long-term outcomes after radiosurgery for glomus jugulare tumors |
3 |
| Neoadjuvant therapy for breast cancer |
3 |
| Diffusion-weighted imaging in evaluating the efficacy of concurrent chemoradiotherapy in the treatment of non-small cell lung cancer |
3 |
| Stereotactic body radiotherapy for lung oligometastases: Literature review according to PICO criteria |
3 |
| Improving healthcare in pediatric oncology: development and testing of multiple indicators to evaluate a hub-and-spoke model |
3 |
| Performance of tumor testing for Lynch syndrome identification in patients with colorectal cancer: A retrospective single-center study |
3 |
| Update on small bowel surveillance in hereditary colorectal cancer syndromes |
3 |
| Up-regulated HMGB1 in the pleural effusion of non-small cell lung cancer (NSCLC) patients reduces the chemosensitivity of NSCLC cells |
2 |
| Equipment, staffing, and provision of radiotherapy in Lombardy, Italy: Results of three surveys performed between 2012 and 2016 |
2 |
| Cancer incidence and mortality trends from 2003 to 2014 in Italy |
2 |
| Unusual skin toxicity associated with sustained disease response induced by nivolumab in a patient with non-small cell lung cancer |
2 |
| Association of MNS16A VNTR and hTERT rs2736098: G > A polymorphisms with susceptibility to diffuse large B-cell lymphoma |
2 |
| Shoulder girdle impairment in breast cancer survivors: the role of range of motion as predictive factor for dose distribution and clinical outcome |
2 |
| Impact of breast cancer screening in a population with high spontaneous coverage with mammography |
2 |
| Unmet needs of Italian cancer patients in different stages of the disease and care process |
2 |
| Blood neutrophil-to-lymphocyte ratio is associated with prognosis in advanced gastrointestinal stromal tumors treated with imatinib |
2 |
| The role of MRI in predicting Ki-67 in breast cancer: preliminary results from a prospective study |
2 |
| Biliary tract rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Associazione Italiana Ematologia Oncologia Pediatrica |
2 |
| New requirements for phase I trials: a challenge for Italian clinical research |
2 |
| Stable knockdown of ZBTB7A promotes cell proliferation and progression in nasopharyngeal carcinoma |
2 |
| Neoadjuvant chemotherapy followed by interval debulking surgery for unresectable stage IVB Serous endometrial cancer |
2 |
